https://www.worldpharmaceuticals.net/news/bayer-moma-collaborate-on-small-molecule-oncology-programme/ 2024-10-09T09:21:40+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-27.webp https://www.worldpharmaceuticals.net/news/astellas-licenses-aviadobios-dementia-asset-in-potential-2-2bn-deal/ 2024-10-09T11:58:59+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/brain-1787622_1920.webp https://www.worldpharmaceuticals.net/news/gsk-reveals-positive-three-season-data-for-arexvy-rsv-vaccine-protection/ 2024-10-09T12:07:58+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-GSKH.webp https://www.worldpharmaceuticals.net/news/uks-mhra-approves-iqirvo-to-treat-pbc/ 2024-10-09T12:55:10+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-30.webp https://www.worldpharmaceuticals.net/news/boehringer-and-circle-pharma-enter-607m-oncology-therapy-deal/ 2024-10-10T07:47:04+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/Boehringer-Ingelheim-Chemical-Center-of-Competence-in-Shanghai.webp https://www.worldpharmaceuticals.net/news/fda-accepts-bayers-new-drug-application-for-vms-therapy-elinzanetant/ 2024-10-10T07:56:18+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/The-bayer-crossdefault.webp https://www.worldpharmaceuticals.net/news/lilly-and-insitro-partner-to-develop-novel-drugs-for-metabolic-diseases/ 2024-10-10T12:05:40+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/09/New-Project-286.webp https://www.worldpharmaceuticals.net/news/viatris-unveils-positive-results-for-effexor-in-japan/ 2024-10-10T12:46:49+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-38.webp https://www.worldpharmaceuticals.net/news/fda-approves-genentechs-itovebi-for-advanced-breast-cancer-with-pik3ca-mutation/ 2024-10-11T07:18:13+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/4076.webp https://www.worldpharmaceuticals.net/news/eversana-partners-with-oracle-argus-cloud/ 2024-10-11T08:07:14+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-55.webp https://www.worldpharmaceuticals.net/news/pfizer-announces-positive-results-for-talzenna-plus-xtandi/ 2024-10-11T10:31:58+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-58.webp https://www.worldpharmaceuticals.net/news/sanofi-in-talks-with-cdr-for-sale-of-controlling-stake-in-opella/ 2024-10-11T12:25:11+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/Sanofi_Frankfurt_IPH-1.webp https://www.worldpharmaceuticals.net/news/pfizer-hympavzi-to-treat-haemophilia-a-or-b/ 2024-10-14T11:00:42+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-67.webp https://www.worldpharmaceuticals.net/news/ailux-janssen-to-advance-biologics-ai-platform/ 2024-10-14T12:27:31+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-69.webp https://www.worldpharmaceuticals.net/news/roche-gets-fda-nod-for-itovebi-to-treat-advanced-breast-cancer/ 2024-10-14T14:46:16+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/312708.webp https://www.worldpharmaceuticals.net/news/lundbeck-to-acquire-longboard-pharma/ 2024-10-15T08:31:04+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-85.webp https://www.worldpharmaceuticals.net/news/samsung-biologics-launches-s-hicon-drug-development-platform/ 2024-10-15T10:36:52+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-88.webp https://www.worldpharmaceuticals.net/news/cycle-confirms-488m-all-cash-second-bid-for-vanda/ 2024-10-15T12:30:33+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/gabrielle-henderson-HJckKnwCXxQ-unsplash.webp https://www.worldpharmaceuticals.net/news/merck-exelixis-partner-to-assess-cancer-combination-therapies/ 2024-10-15T12:40:04+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/KEYTRUDA1-1.webp https://www.worldpharmaceuticals.net/news/jj-reports-37-decline-in-q3-2024-net-income-to-2-69bn/ 2024-10-16T09:54:14+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-104.webp https://www.worldpharmaceuticals.net/news/accord-biopharma-gets-fda-nod-for-imuldosa-to-treat-chronic-inflammatory-conditions/ 2024-10-16T11:23:39+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/injection-1973104_1920.webp https://www.worldpharmaceuticals.net/news/barda-grants-119m-contract-to-synedgen-for-gi-ars-drug/ 2024-10-16T11:50:01+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/sample-4944424_1920.webp https://www.worldpharmaceuticals.net/news/jazz-reports-positive-results-of-zepzelca-in-lung-cancer-trial/ 2024-10-16T12:21:00+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/upper-body-944557_1920-1.webp https://www.worldpharmaceuticals.net/news/atomvie-radiopharm-partner-for-177lu-betabart-radio-antibody/ 2024-10-16T12:48:01+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-107.webp https://www.worldpharmaceuticals.net/news/viatris-to-market-lexicon-pharmas-sotagliflozin-outside-us-and-europe/ 2024-10-17T09:44:55+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-116.webp https://www.worldpharmaceuticals.net/news/fda-accepts-gsks-gepotidacin-for-priority-review-in-uutis-treatment/ 2024-10-17T10:46:57+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-GSKH-1.webp https://www.worldpharmaceuticals.net/news/mercks-capvaxive-shows-strong-immune-response-in-at-risk-adults/ 2024-10-17T12:05:49+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/CAPVAXIVE-Carton-Front-1.webp https://www.worldpharmaceuticals.net/news/acadia-gets-health-canada-approval-for-daybue/ 2024-10-17T12:41:30+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-119.webp https://www.worldpharmaceuticals.net/news/gsk-and-boston-university-team-up-for-pulmonary-fibrosis-research/ 2024-10-18T07:30:26+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/scientist-holding-lab-syringe.webp https://www.worldpharmaceuticals.net/news/vyalev-gets-fda-approval-for-advanced-parkinsons-disease/ 2024-10-18T12:36:47+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/AbbVie-Campoverde-Italy-Angle-1.webp https://www.worldpharmaceuticals.net/news/mercks-clesrovimab-significantly-cuts-rsv-hospitalisations-in-mk-1654-004-trial/ 2024-10-18T13:08:03+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/Headquarters_Rahway-Site-Entrance_HI-1.webp https://www.worldpharmaceuticals.net/news/sanofi-and-orano-enter-radioligand-drug-development-deal/ 2024-10-18T13:10:14+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/laboratory-563423_1920.webp https://www.worldpharmaceuticals.net/news/astellas-gets-fda-approval-for-vyloy-plus-chemotherapy/ 2024-10-21T08:44:37+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-130.webp https://www.worldpharmaceuticals.net/news/charles-river-to-produce-fibrobiologics-therapies/ 2024-10-21T11:23:40+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-133.webp https://www.worldpharmaceuticals.net/news/health-canada-approves-arcutis-zoryve-for-seborrheic-dermatitis/ 2024-10-21T14:15:49+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/zoryve-60g-canister-v04-1.webp https://www.worldpharmaceuticals.net/news/roches-vabysmo-boosts-vision-in-underrepresented-dme-populations/ 2024-10-21T14:35:11+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/312451.webp https://www.worldpharmaceuticals.net/news/sanofi-cdr-in-talks-over-50-stake-in-opella/ 2024-10-22T09:19:47+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-145.webp https://www.worldpharmaceuticals.net/news/editas-genevant-partner-to-develop-gene-editing-drugs/ 2024-10-22T11:05:19+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-147.webp https://www.worldpharmaceuticals.net/news/samsung-biologics-bags-1-24bn-contract-manufacturing-deal/ 2024-10-22T13:38:57+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/cf353a62c413a7922892be73d1419a8dfc378135.webp https://www.worldpharmaceuticals.net/news/novo-nordisks-semaglutide-lowers-mace-risk-in-soul-trial/ 2024-10-22T13:47:40+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/original-1.webp https://www.worldpharmaceuticals.net/news/pfizer-abrysvo-approved-for-at-risk-adults/ 2024-10-23T07:16:16+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-153.webp https://www.worldpharmaceuticals.net/news/telix-to-spin-off-rhine-pharma-to-boost-radiopharmaceutical-access/ 2024-10-23T12:09:06+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/hospital-3089884_1920.webp https://www.worldpharmaceuticals.net/news/servier-secures-health-canada-approval-for-voranigo/ 2024-10-23T12:30:35+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-158.webp https://www.worldpharmaceuticals.net/news/otsukas-sibeprenlimab-meets-primary-endpoint-in-phase-3-visionary-trial/ 2024-10-23T13:20:43+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/robina-weermeijer-sRXCFkJahGk-unsplash-1.webp https://www.worldpharmaceuticals.net/news/merck-acquires-cancer-therapeutics-maker-modifi-for-1-3bn/ 2024-10-24T07:28:27+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-170.webp https://www.worldpharmaceuticals.net/news/lillys-alzheimers-drug-kisunla-approved-in-great-britain/ 2024-10-24T09:21:33+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-171.webp https://www.worldpharmaceuticals.net/news/sk-bioscience-gets-indonesias-bpom-approval-for-skycellflu/ 2024-10-24T12:04:49+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/SKYCellflu_Quadrivalent_prefilled_syringe.webp https://www.worldpharmaceuticals.net/news/ec-approves-darzalex-sc-with-vrd-for-newly-diagnosed-multiple-myeloma-patients/ 2024-10-24T13:49:39+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/plasma-933193_1920.webp https://www.worldpharmaceuticals.net/news/dyno-therapeutics-roche-sign-1-05bn-deal-for-neurological-gene-therapy-development/ 2024-10-25T06:52:40+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/204728.webp https://www.worldpharmaceuticals.net/news/immunitybio-begins-dosing-in-phase-1-trial-of-car-nk-therapy-for-relapsed-nhl/ 2024-10-25T07:22:51+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/dna-6560897_1920-1.webp https://www.worldpharmaceuticals.net/news/keytruda-wins-two-new-approval-for-gynaecologic-cancers/ 2024-10-25T11:34:37+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/KEYTRUDA1-1-1.webp https://www.worldpharmaceuticals.net/news/lyell-to-acquire-cell-therapy-company-immpact-bio/ 2024-10-25T12:33:34+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/syringe-1884784_1920.webp https://www.worldpharmaceuticals.net/news/bora-acquires-pyros-pharmaceuticals/ 2024-10-28T09:07:02+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-181.webp https://www.worldpharmaceuticals.net/news/sanofi-reports-12-increase-in-q3-2024-net-income-to-e2-48bn/ 2024-10-28T12:22:25+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-184-1.webp https://www.worldpharmaceuticals.net/news/fda-approves-iterums-orlynvah-for-urinary-tract-infection/ 2024-10-28T12:38:24+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/nappy-bLfk3zUY5UY-unsplash.webp https://www.worldpharmaceuticals.net/news/novartis-fabhalta-shows-promise-in-phase-3-kidney-disease-trial/ 2024-10-28T12:50:02+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/novartis-campus-forum-1-banting-1-fabrikstrasse-1.webp https://www.worldpharmaceuticals.net/news/abbvie-to-acquire-aliada-for-1-4bn/ 2024-10-29T07:48:40+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-6.webp https://www.worldpharmaceuticals.net/news/monte-rosa-taps-novartis-to-advance-its-mgd-based-medicines/ 2024-10-29T12:04:44+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-9.webp https://www.worldpharmaceuticals.net/news/vaxxas-licenses-next-gen-vaccine-antigen-for-rsv-from-us-nih/ 2024-10-29T12:39:09+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/Vaxxas_HD-MAP_vaccine_patch.webp https://www.worldpharmaceuticals.net/news/ec-approves-expanded-use-of-edurant-for-younger-paediatric-hiv-1-patients/ 2024-10-29T12:50:48+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/national-institute-of-allergy-and-infectious-diseases-hF1tBYwytSI-unsplash.webp https://www.worldpharmaceuticals.net/news/pfizer-reports-q3-2024-net-income-4-46bn/ 2024-10-30T09:30:43+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-18.webp https://www.worldpharmaceuticals.net/news/gsk-to-buy-chimagens-autoimmune-asset-cmg1a46-for-up-to-850m/ 2024-10-30T11:36:14+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/scientist-holding-lab-syringe-1.webp https://www.worldpharmaceuticals.net/news/novartis-scemblix-secures-fda-accelerated-approval-for-chronic-myeloid-leukaemia/ 2024-10-30T12:46:08+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/fabrikstrasse-2-vittorio-magnago-lampugnani-novartis-campus-basel.webp https://www.worldpharmaceuticals.net/news/abbvie-reports-q3-2024-net-income-of-1-56bn/ 2024-10-31T06:23:36+00:00 https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/10/New-Project-1-1.webp